Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis
BelgiumStudy on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis
AustriaStudy on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency
The NetherlandsStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
FranceStudy on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases
GermanyStudy Comparing Romiplostim and Dexamethasone with Dexamethasone Alone for Patients with Newly Diagnosed Primary Immune Thrombocytopenia
ItalyStudy on Batoclimab for Patients with Thyroid Eye Disease
BelgiumStudy on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V
FranceStudy on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis
PolandStudy on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis
BulgariaStudy on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis
BelgiumStudy on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
